EXPLORE MORE CATEGORIES
- Home
- ยป
- Our Products
- »
- Anti Cancer Tablets
Anti Cancer Tablets
Our range of products include thioguanine 40 mg tablets, 50mg ablu bicalutamide tablet, 200mg sorafenat sorafenib tosylate tablet, 10mg xarelto rivaroxaban tablet, 400 mg apotinib imatinib mesylate tablets and apatinib mesylate tablets.
Thioguanine 40 mg Tablets
Product Price: Rs 180 / StripGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 40 mg |
| Packaging Size | 10 Tablets in 1 Strip |
| Composition | Thioguanine 40 mg |
| Brand Name | 6 TG 40 mg Tablet |
| Manufacturer | Miracalus Pharma Ltd |
| Treatment | Blood cancer |
40 mg Thioguanine Tablets
Overview:Thioguanine 40 mg Tablets are an oral chemotherapy medication containing Thioguanine, a purine analog used in the treatment of certain types of cancer, including acute leukemia. Thioguanine is classified as an antimetabolite and works by interfering with the synthesis of DNA in cancer cells. By incorporating into the DNA structure, Thioguanine disrupts the normal replication and function of DNA, leading to cell death. It is typically used in combination with other chemotherapeutic agents as part of a combination chemotherapy regimen.
Indications:Thioguanine 40 mg Tablets are indicated for:
- Acute Myelogenous Leukemia (AML): As part of combination therapy for patients with AML, especially in the maintenance phase or for patients who cannot tolerate other therapies.
- Chronic Myelogenous Leukemia (CML): In patients who have failed previous therapies or are intolerant to other treatments.
- Other Leukemias: Sometimes used off-label in the treatment of other hematologic cancers.
Thioguanine is a purine analog, similar to the natural purines adenine and guanine. Once inside the body, Thioguanine is converted into its active metabolites, thioguanine nucleotides. These metabolites are incorporated into the DNA and RNA of cancer cells, disrupting their normal function. This inhibits DNA replication and cell division, which is particularly effective in rapidly dividing cells such as leukemia cells. By inhibiting purine metabolism, Thioguanine prevents cancer cells from multiplying, thus slowing or halting tumor growth.
Dosage and Administration:- Recommended Dose: 40 mg once daily for most adults, taken orally. The dosage may vary depending on the patient's specific condition, and adjustments may be necessary based on tolerance and blood counts.
- Administration: Swallow the tablet whole with a glass of water. It can be taken with or without food. Ensure regular blood monitoring during treatment to assess for side effects and adjust the dosage accordingly.
- Common Side Effects: Nausea, vomiting, diarrhea, loss of appetite, and bone marrow suppression, which may lead to anemia, leukopenia, or thrombocytopenia.
- Serious Side Effects: Liver toxicity, pancreatitis, gastrointestinal bleeding, and infections due to low white blood cell counts. Regular monitoring of liver function, blood counts, and overall health is essential during therapy.
- Bone Marrow Suppression: Thioguanine can cause significant myelosuppression, so blood cell counts must be monitored regularly.
- Liver Function: Monitor for signs of liver toxicity, as Thioguanine can cause liver damage. Liver function tests should be performed during treatment.
- Pregnancy and Lactation: Thioguanine is contraindicated during pregnancy and breastfeeding. Effective contraception should be used during treatment.
Store Thioguanine 40 mg Tablets at room temperature (15°C to 30°C), away from light and moisture. Keep the medication out of reach of children.
Conclusion:Thioguanine 40 mg Tablets are an essential treatment for acute leukemia and other hematologic cancers. By interfering with DNA synthesis, Thioguanine helps to slow or stop the growth of cancer cells. Regular monitoring of blood counts, liver function, and overall health is crucial for managing potential side effects and ensuring the safety and effectiveness of the treatment.
Yes! I am InterestedRequest A Callback
50mg Ablu Bicalutamide Tablet
Product Price: Rs 150 / PackGet Best Price
Minimum Order Quantity: 10 Pack
Product Brochure
Product Details:
| Form | Tablet |
| Brand | Neon |
| Pack Type | Box |
| Pack Size | 3x10 Tablet |
| Strength | 50mg |
| Usage | Used To Treat Cancer |
| Shelf Life | 2 Years |
-
50mg Ablu Bicalutamide Tablet
Overview:
Ablu 50mg Tablet contains Bicalutamide, a non-steroidal anti-androgen used in the treatment of prostate cancer. Bicalutamide works by blocking the action of androgens (male hormones) like testosterone that stimulate the growth of prostate cancer cells. By inhibiting the androgen receptors, Bicalutamide reduces the growth of cancer cells, particularly in metastatic prostate cancer.Indications:
Ablu 50mg Tablet is primarily indicated for:- Prostate Cancer: Treatment of locally advanced, metastatic, or hormone-dependent prostate cancer.
- Adjuvant Therapy: Often used in combination with LHRH agonists (luteinizing hormone-releasing hormone) as part of androgen deprivation therapy (ADT) in prostate cancer.
Mechanism of Action:
Bicalutamide acts by competitively binding to androgen receptors on prostate cancer cells, preventing testosterone and other androgens from activating these receptors. This reduces the ability of cancer cells to grow and divide. Unlike other treatments, Bicalutamide does not lower the production of testosterone but blocks its action at the receptor level.Dosage and Administration:
- Recommended Dose: The usual dose of Ablu 50mg is one tablet daily, taken orally at the same time each day. It is commonly administered in combination with LHRH agonists for enhanced efficacy.
- Administration: The tablet should be swallowed whole with water, with or without food. Do not chew, break, or crush the tablet.
- Monitoring: Regular monitoring of liver function and prostate-specific antigen (PSA) levels is recommended during treatment.
Side Effects:
Common side effects include:- Hot flashes, fatigue, and nausea.
- Gynecomastia (breast tenderness or enlargement) and reduced libido.
- Diarrhea and constipation.
Serious side effects may include:
- Liver toxicity: Bicalutamide can cause liver dysfunction, so liver function tests should be monitored regularly.
- Cardiovascular issues: Rarely, it can increase the risk of heart disease or lung toxicity.
Precautions:
- Liver function: Bicalutamide should be used with caution in patients with liver impairment. Regular liver function monitoring is necessary.
- Pregnancy and Breastfeeding: Bicalutamide is contraindicated during pregnancy and breastfeeding as it may harm the fetus or infant.
- Caution in pre-existing heart conditions: Patients with cardiovascular diseases should be monitored during treatment.
Storage:
Store Ablu 50mg Tablets at room temperature (20°C to 25°C), away from light, moisture, and heat.Conclusion:
Ablu 50mg Bicalutamide Tablets are an effective treatment for hormone-dependent prostate cancer. By blocking androgen receptors, Bicalutamide slows or halts cancer cell growth. Regular monitoring of liver function and PSA levels is crucial to ensure patient safety and treatment efficacy.
Yes! I am InterestedRequest A Callback
200mg Sorafenat Sorafenib Tosylate Tablet
Product Price: Rs 4,350 / BottleGet Best Price
Product Brochure
Product Details:
| Packaging Size | 120 Tablets |
| Strength | 200 mg |
| Form | Tablet |
| Brand | Natco |
| Pack Type | Box |
| Usage | Used To Treat Kidney Cancer |
Overview:
Sorafenat 200 mg Tablets contain Sorafenib, an oral multi-kinase inhibitor used in the treatment of various cancers. Sorafenib works by inhibiting the activity of several kinases involved in the growth of cancer cells and the formation of blood vessels that supply tumors (angiogenesis). It blocks signaling pathways that promote tumor growth, including Raf kinase and vascular endothelial growth factor receptor (VEGFR).
- Hepatocellular Carcinoma (HCC): For the treatment of advanced liver cancer (hepatocellular carcinoma) that cannot be surgically removed or has spread.
- Renal Cell Carcinoma (RCC): For advanced renal cell carcinoma (kidney cancer), typically in combination with other therapies.
- Differentiated Thyroid Cancer: For progressive, metastatic differentiated thyroid cancer that is refractory to radioactive iodine treatment.
- Other Cancers: Sorafenib is sometimes used off-label for other cancers, including soft tissue sarcomas and bladder cancer.
Sorafenib is a tyrosine kinase inhibitor (TKI) that targets multiple receptors involved in tumor growth and angiogenesis. It inhibits Raf kinase (a key driver in cell growth), VEGFR, PDGFR, and other kinases involved in tumor blood vessel formation. This multi-targeted action results in tumor growth inhibition and reduced metastasis.
Dosage and Administration:- Hepatocellular Carcinoma (HCC): The recommended dose is 400 mg twice daily (morning and evening) for as long as the patient tolerates the drug.
- Renal Cell Carcinoma (RCC): The standard dose is 400 mg twice daily, taken continuously until disease progression or unacceptable toxicity occurs.
- Differentiated Thyroid Cancer: The dose is usually 400 mg twice daily.
- Administration: Take orally with or without food. Swallow tablets whole with water. Do not crush or chew the tablets.
Common: Diarrhea, fatigue, rash, high blood pressure, nausea, loss of appetite, and hand-foot skin reaction (redness, swelling, pain).
Serious: Liver toxicity, severe bleeding, heart problems, hypertension, and hand-foot syndrome.
Monitor: Regular liver function tests, blood pressure monitoring, and skin assessments are recommended.
- Liver Function: Use with caution in patients with liver disease or liver dysfunction. Regular monitoring of liver enzymes is required.
- Hypertension: Sorafenib may increase blood pressure; monitor regularly and treat accordingly.
- Bleeding Risk: Sorafenib can increase the risk of severe bleeding. Caution is required in patients with a history of bleeding disorders.
- Pregnancy and Lactation: Contraindicated during pregnancy due to potential fetal harm. Avoid breastfeeding while on treatment.
Store Sorafenat 200 mg Tablets at room temperature (15°C to 30°C) in a dry place, away from light and moisture. Keep out of reach of children.
Conclusion:Sorafenat 200 mg Tablets (Sorafenib) is an oral multi-kinase inhibitor used in the treatment of advanced liver cancer, renal cell carcinoma, and thyroid cancer. By targeting multiple pathways involved in tumor growth and blood vessel formation, Sorafenib helps to slow down cancer progression. Regular monitoring for liver function, blood pressure, and skin reactions is essential during treatment.
Yes! I am InterestedRequest A Callback
10mg Xarelto Rivaroxaban Tablet
Product Price: Rs 500 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 10 mg |
| Packaging Size | 10 Tablets |
| Brand | Bayer |
| Form | Tablet |
| Usage | Used To Treat Blood Clots |
Xarelto 10mg Tablet is a medicine known as an anticoagulant or blood thinner. It helps prevent and treat blood clots. It is used to reduce the risk of stroke and heart attack. It prevents and treats clot formation in the veins of your legs, lungs, brain and heart.
Xarelto 10mg Tablet is commonly used in patients with irregular heart rhythm (atrial fibrillation) to prevent clot formation. It also reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries. It should be taken with food and it is best to take them at the same time each day. You may need to take this medicine for many years, even for life in some cases. Do not stop taking it or change the dose without guidance from your doctor. It could quickly put you more at risk of having a heart attack, stroke, or thrombosis (formation of a blood clot within a blood vessel). You can reduce your risk of having a blood clot by making changes to your lifestyle, such as not smoking, eating a healthy diet, getting regular exercise, and losing weight if you need to.
Yes! I am InterestedRequest A Callback
400 mg Apotinib Imatinib Mesylate Tablets
Product Price: Rs 564 / BoxGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 400 mg |
| Packaging Size | 30 Tablets |
| Composition | Imatinib mesylate (400 mg) |
| Brand Name | Apotinib 400 Tablet |
| Manufacturer | BDR Pharmaceuticals Internationals Pvt |
| Treatment | Blood cancer (Chronic myeloid leukaemia) |
Thioguanine 40 mg (6 TG) Tablets
Overview:
Thioguanine 40 mg (6 TG) Tablets contain Thioguanine, an antimetabolite chemotherapy medication. It is primarily used to treat acute leukemia by inhibiting DNA synthesis and cell division in cancer cells. Thioguanine is a purine analog that disrupts normal DNA and RNA function, leading to cancer cell death.
Indications:
- Acute Myelogenous Leukemia (AML): Used in combination with other chemotherapy agents for AML treatment.
- Chronic Myelogenous Leukemia (CML): Applied in cases where other treatments are ineffective.
Mechanism of Action:
Thioguanine is incorporated into the DNA of rapidly dividing cells and is converted into 6-thioguanine nucleotide. This compound interferes with purine nucleotide synthesis, disrupting DNA replication and RNA transcription, leading to cell death.
Dosage and Administration:
- Acute Leukemia: Typically 40 mg daily, often in combination with other chemotherapy drugs.
- CML: 40 mg daily, with possible dose adjustments based on response and tolerance.
- Administration: Take the tablet whole, with or without food. Do not crush or chew. Ensure adequate hydration.
Side Effects:
- Common: Nausea, vomiting, fatigue, bone marrow suppression, liver toxicity.
- Serious: Infections (due to immunosuppression), liver failure, severe bone marrow suppression, gastrointestinal bleeding.
- Monitor: Regular blood tests for liver function, blood cell counts, and bone marrow suppression are needed.
Precautions:
- Bone Marrow Suppression: Monitor blood counts regularly for anemia, thrombocytopenia, and leukopenia.
- Liver Dysfunction: Monitor liver function, especially in patients with preexisting liver disease.
- Pregnancy and Lactation: Contraindicated during pregnancy due to teratogenic effects; avoid during breastfeeding.
Storage:
Store at room temperature (15°C to 30°C), away from light and moisture. Keep out of reach of children.
Conclusion:
Thioguanine 40 mg (6 TG) Tablets effectively treat AML and CML by inhibiting DNA synthesis and inducing cell death. Regular monitoring for side effects such as bone marrow suppression and liver toxicity is essential during treatment.
Yes! I am InterestedRequest A Callback
Apatinib Mesylate Tablets
Product Price: Rs 500 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 0.25g |
| Packaging Size | 30 Tablet in 1 Box |
| Composition | Apatinib mesylate tablet |
| Brand | Apatinib tablets |
| Manufacturer | Jiangsu Hengrui Pharmaceutical |
| Treatment | Advanced liver cancer |
Yes! I am InterestedRequest A Callback
Glivec Imatinib 100 mg Tablets
Product Price: Rs 650 / StripeGet Best Price
Product Brochure
Product Details:
| Strength | 100 mg |
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 5x10 Tab |
| Medicine brand | Glivec |
| Medicine form | Tablet |
| Medicine name | Imatinib mesylate tablets ip |
| Medicine strength | 100 mg |
| Packaging size | 6x10 |
| Packaging type | Box |
| Salt composition | Imatinib mesylate |
Yes! I am InterestedRequest A Callback
Kryxana 200mg Ribociclib Tablet
Product Price: Rs 19,500 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 200 mg |
| Form | Tablet |
| Brand Name | Kryxana 200 mg |
| Composition | Ribociclib 200mg |
| Manufactured By | Novartis India Ltd |
Kryxana 200 mg Tablet contains Ribociclib, a CDK4/6 inhibitor used in hormone-receptor-positive (HR+), HER2-negative advanced breast cancer. It slows cancer growth by blocking proteins that drive uncontrolled cell division.
Indications-
Advanced or Metastatic Breast Cancer: With hormonal therapy for HR+, HER2-negative cancer.
-
First-line Therapy: Often used in combination with aromatase inhibitors or fulvestrant.
Ribociclib blocks CDK4/6, enzymes that regulate cell division. This stops cancer cells from multiplying and slows tumor growth.
Dosage-
Typical Dose: 600 mg daily (three 200 mg tablets) for 21 days, then 7 days off per 28-day cycle.
-
Take at the same time daily with or without food. Swallow whole.
-
Allergy to Ribociclib
-
Severe liver disease (unless adjusted)
-
Pregnancy or breastfeeding
-
Heart Monitoring: May affect heartbeat (QT prolongation).
-
Blood Tests: Regular monitoring of liver and blood counts.
-
Infections: Report fever or sore throat.
-
Avoid Grapefruit: Can increase side effects.
-
Nausea, fatigue, diarrhea
-
Hair thinning, rash
-
Low blood counts (neutropenia)
-
Irregular heartbeat or dizziness
-
Severe infection or fever
-
Yellowing of skin/eyes (liver issues)
-
Shortness of breath or extreme fatigue
-
CYP3A4 inhibitors/inducers (ketoconazole, rifampicin)
-
QT-prolonging drugs
-
Hormonal therapies or anticoagulants
-
Store below 30°C away from moisture and sunlight.
-
Keep out of reach of children.
-
Take exactly as prescribed.
-
Avoid grapefruit and alcohol.
-
Report infection signs, heart changes, or unusual fatigue.
-
Use effective contraception during and for three weeks after therapy.
Kryxana 200 mg Tablet (Ribociclib) is a targeted therapy for HR+ / HER2- advanced breast cancer. Combined with hormonal therapy, it slows tumor growth. Adherence and monitoring are key for safety and effectiveness.
Yes! I am InterestedRequest A Callback
Evista Raloxifene Hydrochloride (Raloxiheal Tablet)
Product Price: Rs 250 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 60 mg |
| Pack Size | 10 Tablets in 1 Strip |
| Composition (Salt) | Raloxifene Hydrochloride 60 mg |
| Brand Name | Raloxiheal Tablet |
| Manufacturers | Healing Pharma |
| Treatment | Osteoporosis |
Evista Raloxifene Hydrochloride (Raloxiheal Tablet)
Overview:Evista (Raloxifene Hydrochloride), also known as Raloxiheal Tablet, is a selective estrogen receptor modulator (SERM) used primarily in the prevention and treatment of osteoporosis in postmenopausal women. It also reduces the risk of breast cancer in women with osteoporosis or those at high risk. Raloxifene mimics estrogen’s beneficial effects on bone density but does not have the same effects on the breast and uterine tissues, making it a safer alternative to hormone replacement therapy (HRT).
Indications:Evista (Raloxiheal) is indicated for:
- Prevention and Treatment of Osteoporosis: In postmenopausal women, Evista helps to increase bone mass and reduce the risk of fractures.
- Breast Cancer Risk Reduction: In postmenopausal women with osteoporosis or at high risk of breast cancer, Evista has been shown to reduce the incidence of invasive breast cancer.
Raloxifene works by binding to estrogen receptors in bone tissue, exerting estrogen-like effects that help maintain bone mineral density and reduce the rate of bone resorption. By doing so, it helps to increase bone strength and reduce the risk of fractures in postmenopausal women. In breast and uterine tissue, however, Raloxifene acts as an estrogen antagonist, meaning it blocks the effects of estrogen, reducing the risk of estrogen-driven breast cancers.
Dosage and Administration:- Recommended Dose: The usual dose is one 60 mg tablet daily.
- Administration: Take the tablet orally, with or without food. It should be swallowed whole with water. It’s important to take Raloxiheal regularly to maximize its effectiveness in preventing bone loss and reducing the risk of breast cancer.
- Common Side Effects: Hot flashes, leg cramps, flu-like symptoms, joint pain, and sweating.
- Serious Side Effects: Blood clots, deep vein thrombosis (DVT), pulmonary embolism, and stroke. Women with a history of blood clots or those who are immobile should be monitored carefully.
- Blood Clots: Raloxifene can increase the risk of blood clots. Women with a history of DVT, pulmonary embolism, or stroke should avoid Raloxifene.
- Liver Function: Monitor liver enzymes, as Raloxifene can impact liver function in some patients.
- Pregnancy and Lactation: Contraindicated during pregnancy as it can harm the fetus. It is not recommended during breastfeeding.
Store Evista (Raloxiheal) tablets at room temperature (15°C to 30°C), away from light and moisture. Keep out of reach of children.
Conclusion:Evista Raloxifene Hydrochloride (Raloxiheal Tablets) offers a dual benefit for postmenopausal women, promoting bone health and reducing breast cancer risk. While generally well tolerated, it requires monitoring for blood clot risk and liver function. Regular follow-up with healthcare providers ensures safe and effective use of this medication.
Yes! I am InterestedRequest A Callback
10mg Cytotam Tamoxifen Citrate Tablet
Product Price: Rs 110 / StripGet Best Price
Product Brochure
Product Details:
| Dosage/Strength | 10 mg |
| Form | Tablet |
| Brand | Cipla |
| Pack Size | 10x10 Tablets |
| Pack Type | Box |
| Shelf Life | 24 Months |
| Usage | Used To Treat And Prevent Breast Cancer |
Yes! I am InterestedRequest A Callback
Thioguanine 40 mg 6 Tg Tablets
Product Price: Rs 185 / BoxGet Best Price
Minimum Order Quantity: 10 Box
Product Brochure
Product Details:
| Form | Tablet |
| Dose/Strength | 40 mg |
| Packaging Size | 10 tablets in 1 strip |
| Composition | Thioguanine 40 mg |
| Brand Name | 6 TG 40mg Tablet |
| Manufacturer | Miracalus Pharma Ltd. |
| Treatment | Blood cancer |
Overview:
Thioguanine 40 mg (6 TG) Tablets contain Thioguanine, a chemotherapy medication that belongs to the class of antimetabolites. It is used primarily in the treatment of certain cancers, particularly acute leukemia, by inhibiting DNA synthesis and cellular division in cancer cells. Thioguanine is an oral purine analog that works by disrupting the normal functioning of DNA and RNA, ultimately leading to cell death.
- Acute Myelogenous Leukemia (AML): For the treatment of acute leukemia, particularly acute myelogenous leukemia (AML), in combination with other chemotherapy agents.
- Chronic Myelogenous Leukemia (CML): Thioguanine is used in the treatment of CML, particularly in cases where other treatments have not been effective.
Thioguanine is an antimetabolite that is incorporated into the DNA of rapidly dividing cells. Once inside the cell, it is converted into its active form, 6-thioguanine nucleotide. This compound interferes with the synthesis of purine nucleotides, essential for DNA replication and RNA synthesis. The incorporation of thioguanine into the DNA disrupts the ability of the cell to divide, leading to cell death.
Dosage and Administration:- Acute Leukemia: The typical dose is 40 mg once daily (or as prescribed by the oncologist), usually in combination with other chemotherapy drugs.
- Chronic Myelogenous Leukemia (CML): The usual dose is 40 mg daily, though dose adjustments may be necessary based on response and tolerance.
- Administration: Swallow the tablet whole with or without food. Do not crush or chew the tablet. Ensure adequate hydration during treatment.
Common: Nausea, vomiting, bone marrow suppression, fatigue, and liver toxicity.
Serious: Severe infections due to immunosuppression, liver failure, bone marrow suppression, and gastrointestinal bleeding.
Monitor: Regular blood tests for liver function, blood cell counts, and bone marrow suppression are necessary.
- Bone Marrow Suppression: Thioguanine can cause severe bone marrow suppression, which may lead to anemia, thrombocytopenia, or leukopenia. Blood counts should be monitored regularly.
- Liver Dysfunction: Thioguanine is metabolized in the liver, and patients with preexisting liver disease should be monitored closely.
- Pregnancy and Lactation: Thioguanine is contraindicated during pregnancy due to its teratogenic effects. It is also not recommended during breastfeeding.
Store Thioguanine 40 mg Tablets at room temperature (15°C to 30°C), in a dry place away from light and moisture. Keep out of reach of children.
Conclusion:Thioguanine 40 mg (6 TG) Tablets is an effective chemotherapy drug for the treatment of acute and chronic leukemias. By inhibiting DNA synthesis and inducing cell death, it helps to control cancer growth. Regular monitoring for bone marrow suppression, liver function, and infection risk is essential during treatment.
Yes! I am InterestedRequest A Callback
2.5mg Xarelto Rivaroxaban Tablet
Product Price: Rs 200 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 2.5 mg |
| Packaging Size | 14 Tablets |
| Brand | Bayer |
| Form | Tablet |
| Shelf Life | 24 Months |
| Usage | Used To Treat Blood Clots |
Xarelto 2.5mg Tablet is commonly used in patients with irregular heart rhythm (atrial fibrillation) to prevent clot formation. It also reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries. It should be taken with food and it is best to take them at the same time each day. You may need to take this medicine for many years, even for life in some cases. Do not stop taking it or change the dose without guidance from your doctor. It could quickly put you more at risk of having a heart attack, stroke, or thrombosis (formation of a blood clot within a blood vessel). You can reduce your risk of having a blood clot by making changes to your lifestyle, such as not smoking, eating a healthy diet, getting regular exercise, and losing weight if you need to.
Yes! I am InterestedRequest A Callback
Celkeran Chlorambucil 5 mg
Product Price: Rs 1,500 / BottleGet Best Price
Product Brochure
Product Details:
| Strength | 5 mg |
| Pack Size | 1*30 Tablets |
| Composition | Chlorambucil 5 mg |
| Brand | Celkeran 5 mg |
| Manufactured By | Celon Laboratories Ltd |
| Treatment | Blood Cancer |
Celkeran 5mg Tablets (Chlorambucil)
Overview:
Celkeran (Chlorambucil) is an alkylating chemotherapy agent used in the treatment of certain cancers, including chronic lymphocytic leukemia (CLL), Hodgkin's lymphoma, and non-Hodgkin's lymphoma. It works by interfering with the DNA of cancer cells, preventing them from dividing and proliferating. Chlorambucil is commonly used when other treatments are ineffective or unsuitable.
Indications:
Celkeran 5mg Tablets are indicated for:
- Chronic Lymphocytic Leukemia (CLL): A type of cancer that affects the blood and bone marrow.
- Hodgkin’s Lymphoma: A cancer of the lymphatic system.
- Non-Hodgkin’s Lymphoma: A group of cancers that affect the lymphatic system.
- Other malignancies: May also be used in other hematologic and solid tumor cancers based on medical advice.
Mechanism of Action:
Chlorambucil is an alkylating agent that binds to the DNA of rapidly dividing cells. This binding interferes with the cell’s ability to replicate its DNA, causing cell death. Chlorambucil specifically targets cancer cells, disrupting their division and reducing tumor growth.
Dosage and Administration:
- Recommended Dose: The usual dose for adults is 0.1–0.2 mg/kg body weight daily, depending on the condition being treated. The dose may vary based on the patient’s response to treatment.
- Administration: Chlorambucil should be taken orally with water. It is recommended to take it at the same time each day. Your healthcare provider will adjust the dosage based on side effects and response.
Side Effects:
Common side effects include:
- Nausea
- Vomiting
- Fatigue
- Loss of appetite
- Bone marrow suppression (low blood cell counts) Serious side effects may include:
- Infections due to low white blood cell count
- Liver toxicity
- Severe allergic reactions (rash, difficulty breathing)
Precautions:
- Bone marrow suppression: Regular blood tests to monitor blood counts are necessary.
- Liver Function: Monitor liver enzymes as Chlorambucil can affect liver function.
- Pregnancy and Breastfeeding: Contraindicated during pregnancy due to potential harm to the fetus.
Storage:
Store Celkeran tablets at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion:
Celkeran (Chlorambucil) 5mg is an effective treatment for CLL, lymphoma, and other cancers. Proper monitoring of blood counts and liver function is essential during treatment to ensure safety and effectiveness.
Yes! I am InterestedRequest A Callback
Fempro Tablets Usp 2.5 mg
Product Price: Rs 60 / StripGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 2.5 mg |
| Packaging Size | 10 Tablets in 1 Strip |
| Composition | Letrozole 2.5 mg |
| Brand Name | Fempro Tablet |
| Manufacturer | Cipla Ltd |
| Treatment | Breast cancer |
Fempro Tablets USP 2.5 mg
Overview:
Fempro (letrozole) is a medication used primarily for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is a type of aromatase inhibitor that works by decreasing the amount of estrogen in the body, which can slow or stop the growth of certain types of breast cancer that require estrogen to grow. Fempro is often used as an adjuvant treatment following surgery, radiation, or chemotherapy, and it may also be used in metastatic breast cancer.
Indications:
Fempro 2.5 mg is primarily indicated for:
- Adjuvant treatment of hormone receptor-positive breast cancer in postmenopausal women.
- Advanced or metastatic breast cancer in women who have already been treated with tamoxifen or other hormonal therapies.
- It may also be used for the treatment of early breast cancer to reduce recurrence risk.
Mechanism of Action:
Letrozole, the active ingredient in Fempro, works by inhibiting the enzyme aromatase, which converts androgens into estrogen. By reducing estrogen levels in the body, Fempro limits the growth of estrogen-dependent tumors, helping prevent cancer cell proliferation. It is most effective in postmenopausal women whose ovaries have stopped producing estrogen.
Dosage and Administration:
- Recommended Dose: The standard dose is 2.5 mg once daily, taken orally with or without food.
- Administration: Fempro tablets should be swallowed whole with water. The treatment duration is typically several years, depending on the patient's response and the type of cancer being treated.
- Missed Dose: If a dose is missed, it should be taken as soon as remembered, but do not take two doses at once.
Side Effects:
Common side effects include:
- Hot flashes
- Fatigue
- Joint pain
- Nausea
- Headache Serious side effects include:
- Osteoporosis: Fempro may decrease bone mineral density.
- Cardiovascular events: In rare cases, heart problems like arrhythmias.
- Liver dysfunction: Liver enzyme changes.
Precautions:
- Bone Health: Monitoring for bone density loss is recommended.
- Pregnancy and breastfeeding: Contraindicated as Fempro may harm the fetus or infant.
- Liver and kidney function: Periodic liver function tests are advised.
Storage:
Store at room temperature (20°C to 25°C), in a dry place, away from light. Keep out of reach of children.
Conclusion:
Fempro 2.5 mg tablets are a vital treatment for postmenopausal women with hormone receptor-positive breast cancer. Careful monitoring for side effects like bone density loss and cardiovascular events is necessary to ensure optimal treatment outcomes.
Yes! I am InterestedRequest A Callback
Imatinib Tablet (Imat 400 mg Tablets)
Product Price: Rs 2,000 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 400 mg |
| Pack Size | 10 Tablets in 1 Strip |
| Compsotion | Imatinib mesylate 400 mg |
| Brand Name | Imat 400 mg Tablets |
| Manufacturer | Zydus Healthcare Limited |
| Treatment | Cancer |
Imatinib Tablet (Imat 400 mg Tablets)
Overview:
Imatinib, marketed under the brand name Imat 400 mg Tablets, is a tyrosine kinase inhibitor used in the treatment of certain types of cancer. It works by inhibiting specific enzymes that contribute to the growth of cancer cells. Imatinib is primarily used in the treatment of chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL), gastrointestinal stromal tumors (GISTs), and other rare cancers. It targets the BCR-ABL protein that causes abnormal cell growth in CML, and it also inhibits other tyrosine kinases involved in tumor growth.
Indications:
Imatinib 400 mg is indicated for:
- Chronic Myelogenous Leukemia (CML): For newly diagnosed and resistant cases.
- Acute Lymphoblastic Leukemia (ALL): For Philadelphia chromosome-positive cases.
- Gastrointestinal Stromal Tumors (GISTs): For treatment of unresectable or metastatic GISTs.
- Other cancers: Imatinib is also used for myelodysplastic/myeloproliferative diseases, hypereosinophilic syndrome, and systemic mastocytosis.
Mechanism of Action:
Imatinib specifically targets and inhibits the activity of BCR-ABL tyrosine kinase, an abnormal enzyme produced by the Philadelphia chromosome in CML. By blocking this enzyme, Imatinib prevents the activation of downstream pathways that would normally promote the proliferation of cancer cells. Imatinib also inhibits KIT, PDGFRA, and other tyrosine kinases involved in tumor growth.
Dosage and Administration:
- Recommended Dose: The typical dose for adults is 400 mg once daily for CML, though the dose may be adjusted based on the patient's response or side effects.
- Administration: Imatinib should be taken with food and a full glass of water to minimize gastrointestinal irritation. Tablets should be swallowed whole; do not chew or crush.
- Missed Dose: If a dose is missed, take it as soon as possible unless it is close to the next dose. Do not take two doses at once.
Side Effects:
Common side effects include:
- Nausea, vomiting
- Fatigue
- Edema (swelling)
- Muscle cramps
- Headache Serious side effects include:
- Cardiovascular issues: Edema, heart failure.
- Hepatotoxicity: Liver function may be affected.
- Myelosuppression: Decreased blood cell counts.
Precautions:
- Liver and kidney function: Liver function tests should be monitored.
- Pregnancy: Should be used only when necessary as it can harm the fetus.
- Cytopenia: Monitor blood cell counts regularly.
Storage:
Store Imatinib tablets at room temperature (20°C to 25°C), in a dry place, away from moisture and light. Keep out of reach of children.
Conclusion:
Imatinib 400 mg tablets are an essential treatment for several cancers, particularly CML and GISTs. Monitoring for side effects such as liver toxicity and blood cell counts is important to ensure patient safety and treatment effectiveness.
Yes! I am InterestedRequest A Callback
Imatinib Imatirel 400mg Tablet
Product Price: Rs 5,000 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 400 mg |
| Packaging Type | 10 Tablet in 1 Strip |
| Composition | Imatinib 400 mg |
| Brand Name | Imatirel 400 mg |
| Manufacturer | Reliance Life Sciences Pvt Ltd |
| Treatment | Cancer |
Overview: 400mg Imatinib Tablet contains Imatinib, a tyrosine kinase inhibitor used to treat various cancers, including chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Imatinib works by inhibiting abnormal proteins produced by cancer cells, specifically targeting the BCR-ABL fusion protein in CML, and other tyrosine kinases that drive tumor growth.
Indications: Imatinib 400mg Tablet is indicated for:
- Chronic Myelogenous Leukemia (CML): Treatment of Ph+ CML in chronic phase.
- Gastrointestinal Stromal Tumors (GISTs): Treatment of adult patients with unresectable or metastatic GISTs.
- Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
- Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia.
Mechanism of Action: Imatinib inhibits the BCR-ABL tyrosine kinase (produced by the Philadelphia chromosome in CML), along with other tyrosine kinases such as c-Kit (in GISTs) and PDGFR (platelet-derived growth factor receptor). By blocking these abnormal signaling pathways, Imatinib prevents tumor growth and induces cell death.
Dosage and Administration:
- CML (Chronic Phase): 400mg orally once daily.
- GIST: 400mg orally once daily.
- Ph+ ALL: Typically 600mg orally daily for induction, then reduced to 400mg daily for maintenance.
Imatinib should be taken with food and a glass of water to reduce the risk of gastrointestinal irritation.
Side Effects: Common side effects include:
- Edema, fatigue, nausea, muscle cramps, and rash.
- Bone marrow suppression: Neutropenia, thrombocytopenia, and anemia.
- Liver enzyme elevation, diarrhea, and headache.
Serious side effects may include:
- Severe liver toxicity, heart failure, and fluid retention.
- Tumor lysis syndrome, gastrointestinal bleeding, and bleeding complications.
Precautions:
- Blood counts: Regular monitoring of blood counts due to the risk of myelosuppression.
- Liver function: Regular liver function tests to detect hepatotoxicity.
- Heart conditions: Use with caution in patients with heart failure or fluid retention.
- Pregnancy: Imatinib is contraindicated during pregnancy due to potential harm to the fetus.
Storage: Store Imatinib tablets at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion: 400mg Imatinib Tablet is an effective targeted therapy for CML, GISTs, and Ph+ ALL, significantly improving patient outcomes by inhibiting the molecular drivers of cancer growth. Regular monitoring of blood counts, liver function, and cardiovascular health is essential for safe use.
Yes! I am InterestedRequest A Callback
100mg Erlotinib Erlotero Tablet
Product Price: Rs 1,200 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 100 mg |
| Form | Tablet |
| Pack Size | 1*30 Tablet |
| Pack Type | Box |
| Brand Name | Oncology |
| Treatment | Treats non small cell lung cancer |
Erlotero 150mg Tabletis utilized in the therapy of non-little cell cellular breakdown in the lungs and pancreatic disease.
Erlotero 150mg Tabletought to be taken while starving or ought to be required one hour prior or 2 hour after dinner. You ought to keep on accepting it as long as your primary care physician exhorts it. The term of treatment fluctuates as indicated by your requirements and reaction to treatment. You ought to take it precisely as your physician has prompted. Misinterpreting it in or taking an excess of can cause intense secondary effects. It might require a little while or months for you to see or feel the advantages however don't quit taking it except if your primary care physician tells you to.
Yes! I am InterestedRequest A Callback
500mg Capetero Capcitabine Tablets
Product Price: Rs 890 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 500 mg |
| Form | Tablet |
| Pack Size | 1*10 Tablets |
| Pack Type | Box |
| Brand Name | Oncology |
| Shelf Life | 24 Months |
| Usages | To treat certain types of cancer |
and rectum. It veritably well might be likewise used to treat different, not set in
gravestone by the specialist. It's employed alone or in mix with another drug
as a piece of chemotherapy.
Capetero 500mgTablet ought to be taken with food in commodity like 30
twinkles posterior to eating a feast. Your primary care croaker will
choose what portion is abecedarian and how constantly you really want to
take it. This will calculate upon what you're being treated for and may change
every formerly in a while. You ought to take it precisely as your primary care
croaker has urged. Misinterpreting it in or taking an inordinate quantum
of can beget violent secondary goods. It might bear a little while or
months for you to see or feel the advantages still do not quit taking it
except if your PCP tells you to.
Yes! I am InterestedRequest A Callback
Trifuridine Tipiracil Tipanat 15 mg/6.14 mg
Product Price: Rs 5,000 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 15 mg/ 6.14 mg |
| Packaging Size | 20 Tablets in 1 Bottle |
| Dose/Strength | 15 mg/6.14 mg |
| Composition | Trifluridine And Tipiracil 15 mg/6.14 mg |
| Brand Name | Tipanat 15 mg |
| Manufacturer | Natco Pharma Ltd |
| Treatment | Metastatic Colorectal Cancer |
Trifuridine Tipiracil (Tipanat 15mg/16.4mg)
Overview: Trifuridine Tipiracil (Tipanat 15mg/16.4mg) is an oral combination medication used to treat metastatic colorectal cancer. It contains two active ingredients: trifuridine, a nucleoside analogue, and tipiracil, a thymidine phosphorylase inhibitor. This combination works synergistically to block cancer cell division by interfering with DNA replication. Trifuridine is incorporated into the DNA of cancer cells, causing DNA damage and preventing cell proliferation. Tipiracil inhibits the breakdown of trifuridine, enhancing its effects.
Indications: Tipanat is indicated for the treatment of metastatic colorectal cancer (CRC) in patients who have previously been treated with other chemotherapy options, such as fluoropyrimidines, oxaliplatin, and irinotecan, or for patients who are intolerant to these therapies. It is used to manage advanced stages of CRC, helping to slow tumor progression and improve patient outcomes.
Mechanism of Action:
- Trifuridine: Once inside cancer cells, trifuridine is converted into active metabolites, which then become incorporated into DNA during replication, leading to DNA damage and triggering cell death.
- Tipiracil: By inhibiting thymidine phosphorylase, tipiracil prevents the premature breakdown of trifuridine, thereby increasing its bioavailability and ensuring its continued action against cancer cells.
Dosage and Administration:
- Recommended Dose: The usual dose is 35 mg/m² twice daily, taken with food on days 1 through 5 and days 8 through 12 of a 28-day treatment cycle. The dose may be adjusted depending on side effects and patient tolerance.
- Administration: Tipanat should be taken orally, with food, and tablets should be swallowed whole without crushing or chewing.
Side Effects: Common side effects include:
- Nausea, vomiting
- Fatigue
- Loss of appetite
- Diarrhea Serious side effects may include:
- Bone marrow suppression: Leading to anemia, neutropenia, and thrombocytopenia.
- Liver toxicity: Monitor liver function during treatment.
- Severe gastrointestinal issues: Including severe nausea and diarrhea.
Precautions:
- Bone Marrow Suppression: Regular monitoring of blood counts is essential.
- Pregnancy: Should not be used during pregnancy due to potential harm to the fetus.
- Liver function: Use with caution in patients with liver impairment.
Storage: Store Tipanat tablets at room temperature (20°C to 25°C), away from light and moisture. Keep out of reach of children.
Conclusion: Trifuridine Tipiracil (Tipanat 15mg/16.4mg) is an effective chemotherapy option for metastatic colorectal cancer, especially for patients who have failed prior treatments. Regular monitoring for side effects and liver function is necessary to ensure treatment safety.
Yes! I am InterestedRequest A Callback
Lapatinib Herlapsa 250 mg Tablet
Product Price: Rs 4,800 / BottleGet Best Price
Product Brochure
Product Details:
| Packaging Size | 250 mg |
| Strength | 250 mg |
| Packaging Type | 30 Tablets In 1 Bottle |
| Composition | Lapatinib 250 mg |
| Brand Name | Herlapsa Tablet |
| Manufacturer | Mylan pharmaceutical Pvt. Ltd |
| Treatment | Breast Cancer |
Lapatinib (Herlapsa 250mg Tablet)
Overview:
Lapatinib (Herlapsa 250mg Tablet) is an oral targeted therapy used in the treatment of specific types of breast cancer, particularly in combination with other medications. It is a tyrosine kinase inhibitor that blocks the action of epidermal growth factor receptors (EGFR) and HER2 (human epidermal growth factor receptor 2) proteins, both of which promote the growth of cancer cells. By inhibiting these receptors, Lapatinib slows the growth and spread of cancer.
Indications:
Lapatinib 250mg Tablet is indicated for:
- HER2-positive breast cancer: In combination with capecitabine for patients with metastatic breast cancer that is HER2-positive.
- Advanced or metastatic breast cancer: In combination with letrozole for postmenopausal women who have hormone receptor-positive breast cancer.
Mechanism of Action:
Lapatinib works by inhibiting the activity of both EGFR and HER2 receptors, which are involved in cancer cell growth and proliferation. By blocking these receptors, Lapatinib reduces tumor cell growth, potentially leading to reduced tumor size and preventing further cancer spread.
Dosage and Administration:
- Recommended Dose: The usual dose is 1250mg once daily orally, taken with or without food.
- Administration: Swallow tablets whole with a glass of water. Do not chew, crush, or split the tablet.
- Missed Dose: If a dose is missed, take it as soon as possible, unless it is nearly time for the next dose. Do not double the dose.
Side Effects:
Common side effects include:
- Diarrhea
- Skin rashes or acne-like reactions
- Fatigue
- Nausea and vomiting
- Decreased appetite Serious side effects may include:
- Liver toxicity: Monitoring liver function is essential during treatment.
- Heart issues: Can cause heart failure or changes in heart rhythm.
- Severe allergic reactions: Rare but may include swelling, difficulty breathing, or skin rashes.
Precautions:
- Liver function: Regular liver enzyme tests are needed.
- Heart conditions: Patients with heart disease should be closely monitored during treatment.
- Pregnancy: Contraindicated during pregnancy as it may harm the fetus.
Storage:
Store Lapatinib tablets at room temperature (20°C to 25°C), away from heat and moisture. Keep out of reach of children.
Conclusion:
Lapatinib (Herlapsa 250mg Tablet) is an effective treatment for HER2-positive breast cancer and is usually prescribed in combination with other chemotherapy agents. Regular monitoring for liver function and heart health is crucial to ensure safety during treatment.
Yes! I am InterestedRequest A Callback
150mg Erlotec Erlotinib Tablet
Product Price: Rs 6,500 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 150 mg |
| Pack Size | 1*10 Tablet |
| Composition | Erlotinib 150 mg |
| Brand | Erlotec 150 mg |
| Manufactured By | United Biotech Pvt.Ltd |
| Treatment of | Pancreatic cancer |
Erlotec (Erlotinib 150 mg Tablet)
Overview: Erlotinib is an oral epidermal growth factor receptor (EGFR) inhibitor used primarily in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by blocking the activity of EGFR, a protein involved in the growth and spread of cancer cells, particularly in cancers with EGFR mutations.
-
Non-Small Cell Lung Cancer (NSCLC): Used for the treatment of metastatic NSCLC with EGFR mutations, particularly in patients who have not previously received chemotherapy.
-
Pancreatic Cancer: Used in combination with gemcitabine for the treatment of locally advanced or metastatic pancreatic cancer.
Erlotinib inhibits the EGFR tyrosine kinase, a critical component in the signaling pathways that control cancer cell growth, survival, and spread. By blocking EGFR, Erlotinib helps to reduce tumor growth and metastasis, particularly in cancers that depend on EGFR signaling due to mutations.
Dosage and Administration:-
Dosage: The usual dose is 150 mg once daily, taken with or without food. The dose may be adjusted based on the patient’s tolerance and side effects.
-
Administration: Swallow the tablet whole. Do not crush or chew the tablet. Take Erlotinib consistently at the same time each day.
- Hypersensitivity: Contraindicated in patients with known hypersensitivity to Erlotinib or any of its components.
-
Interstitial Lung Disease (ILD): Serious lung conditions, such as ILD, may occur. Discontinue Erlotinib if symptoms of ILD (e.g., cough, shortness of breath) develop.
-
Hepatotoxicity: Monitor liver function regularly, as Erlotinib can cause liver damage or elevated liver enzymes.
-
Gastrointestinal Issues: Diarrhea is a common side effect and may require dose adjustments or supportive care.
-
Common: Diarrhea, skin rash, fatigue, and nausea.
-
Serious: Interstitial lung disease, severe diarrhea, hepatotoxicity, and eye problems (e.g., dry eye, irritation).
Erlotinib may interact with drugs that affect the CYP3A4 enzyme, such as antifungals, antibiotics, or anticonvulsants. Patients should inform their healthcare provider about all other medications being taken.
Storage:Store at room temperature (20°C to 25°C / 68°F to 77°F), away from moisture and light. Keep out of reach of children.
Patient Counseling:Patients should take Erlotinib exactly as prescribed. Inform them about potential side effects such as diarrhea, skin rash, and lung problems. Patients should also be instructed to report any signs of liver dysfunction, such as jaundice, or any respiratory symptoms.
Conclusion:Erlotec (Erlotinib 150 mg Tablet) is an effective treatment for NSCLC and pancreatic cancer, particularly for patients with EGFR mutations. Proper administration, monitoring for side effects, and patient education are critical for optimizing treatment outcomes. Always consult a healthcare provider for personalized medical advice.
Yes! I am InterestedRequest A Callback
Clokeran 5 Chlorambucil Tablet
Product Price: Rs 12,550 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 5 mg |
| Form | Tablet |
| Brand | Natco |
| Pack Type | Box |
| Pack Size | 30 Tablets |
| Shelf Life | 24 Months |
| Usage | Used To Treat Some Types Of Blood Cancers Like Hodgkin's Disease |
Overview:
Clokeran 5 mg Tablets contain Chlorambucil, an alkylating agent used in the treatment of various hematologic cancers and autoimmune disorders. Chlorambucil works by interfering with DNA replication and cell division, leading to the death of cancer cells. It is primarily used in the treatment of chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and non-Hodgkin lymphoma, as well as certain autoimmune diseases such as autoimmune hemolytic anemia.
- Chronic Lymphocytic Leukemia (CLL): For the treatment of CLL, often used when other treatments are not effective or feasible.
- Non-Hodgkin Lymphoma: Used as a chemotherapy agent in non-Hodgkin lymphoma.
- Hodgkin Lymphoma: For Hodgkin lymphoma in combination with other chemotherapy drugs.
- Autoimmune Diseases: Used off-label for treating conditions like autoimmune hemolytic anemia and nephrotic syndrome.
Chlorambucil is an alkylating agent that interferes with the DNA of cancer cells by forming cross-links between the strands of DNA. This prevents DNA replication and causes the cell to undergo apoptosis (programmed cell death). Chlorambucil is effective against rapidly dividing cells, making it useful for treating cancers and some autoimmune conditions where cell division is excessive.
Dosage and Administration:- Chronic Lymphocytic Leukemia (CLL): Initial dose of 0.1 to 0.2 mg/kg per day, which may be adjusted based on response and side effects.
- Non-Hodgkin Lymphoma: Dose is typically 4-6 mg daily for 4-8 weeks.
- Autoimmune Disorders: Doses vary based on the specific condition being treated.
- Administration: Taken orally once a day with or without food. Doses should be adjusted based on side effects and blood count results.
Common: Nausea, vomiting, diarrhea, hair loss, and fatigue.
Serious: Bone marrow suppression (neutropenia, thrombocytopenia), liver toxicity, increased risk of infections, and secondary malignancies (e.g., leukemia).
Monitor: Regular blood counts (especially white blood cells, red blood cells, and platelets), liver function tests, and renal function.
- Bone Marrow Suppression: Chlorambucil can cause significant myelosuppression, leading to decreased blood cell counts. Regular monitoring is essential.
- Liver Function: Caution in patients with liver disease, as Chlorambucil is metabolized in the liver.
- Pregnancy and Lactation: Contraindicated during pregnancy and breastfeeding due to teratogenic effects and risk to the fetus.
- Infections: Increased susceptibility to infections due to immunosuppressive effects.
Store at room temperature (15°C to 30°C) in a dry place, away from light. Keep out of reach of children.
Conclusion:Clokeran 5 mg Tablets (Chlorambucil) is an alkylating agent used in the treatment of hematologic cancers such as CLL, Hodgkin lymphoma, and non-Hodgkin lymphoma, as well as some autoimmune diseases. It works by damaging the DNA of rapidly dividing cells, preventing their growth and replication. Regular monitoring of blood counts, liver function, and renal function is essential to minimize the risk of severe side effects.
Yes! I am InterestedRequest A Callback
Bqnat 100mg Tablet
Product Price: Rs 16,450 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 100 mg |
| Packaging Size | 188 Tablet Per Bottle |
| Composition | Bedaquiline 100 mg |
| Manufacturer | Natco Pharma Ltd |
| Brand | Bqnat |
| Treatment | Multidrug-resistant pulmonary tuberculosis (MDR-TB) in adults. |
Bqnat (Baclofen 100 mg Tablet) is a powerful muscle relaxant commonly used to treat muscle spasticity associated with neurological conditions. If you’re searching for effective relief from muscle stiffness and spasms, Bqnat offers a reliable solution to enhance your quality of life.
What is Bqnat?Bqnat contains Baclofen, a medication that acts on the central nervous system to relieve muscle spasticity. It is particularly beneficial for individuals suffering from conditions such as multiple sclerosis, spinal cord injuries, or other neurological disorders.
IndicationsBqnat is indicated for:
- Muscle Spasticity: Helps alleviate symptoms related to conditions like multiple sclerosis and spinal cord injuries.
- Neuropathic Pain: May provide relief from pain caused by nerve damage.
Baclofen works as a GABA-B receptor agonist. By enhancing the inhibitory effects of GABA, it reduces the excitability of neurons, leading to decreased muscle tone and spasticity. This mechanism helps improve movement and reduce discomfort.
Dosage and Administration- Dosage: The typical starting dose is 5 mg, which may be increased gradually based on the patient's response, up to a maximum of 100 mg per day in divided doses.
- Administration: Bqnat should be taken orally with or without food. It's essential to follow the prescribed dosage from your healthcare provider.
Bqnat is contraindicated in:
- Hypersensitivity: Known allergy to Baclofen or any components of the formulation.
- Severe Renal Impairment: Caution is advised in patients with significant kidney issues.
- Withdrawal Symptoms: Sudden discontinuation can lead to withdrawal symptoms. Gradual tapering of the dose is recommended.
- CNS Depression: Use with caution in patients with a history of seizures or other central nervous system disorders.
- Alcohol Interaction: Avoid alcohol while taking Bqnat, as it can enhance drowsiness and dizziness.
Common side effects may include:
- Drowsiness
- Dizziness
- Fatigue
- Nausea
Serious side effects can include:
- Severe allergic reactions (anaphylaxis)
- Confusion or hallucinations
- Respiratory depression
Bqnat may interact with other CNS depressants, such as opioids and alcohol. Always inform your healthcare provider about all medications and supplements you are taking.
Storage InstructionsStore Bqnat (Baclofen 100 mg Tablet) at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
Patient Counseling Information- Advise patients to take Bqnat exactly as prescribed and not to alter the dosage without consulting their healthcare provider.
- Discuss potential side effects and the importance of reporting any severe symptoms.
- Encourage regular follow-up appointments to monitor treatment efficacy and side effects.
Bqnat (Baclofen 100 mg Tablet) is an effective treatment for muscle spasticity and related conditions. Its muscle-relaxing properties can significantly enhance mobility and comfort for those affected by neurological disorders.
Call to ActionIf you or a loved one are experiencing muscle spasticity, consult your healthcare provider about Bqnat and discover how it can help improve your daily life.
Yes! I am InterestedRequest A Callback
Imatinib (Imatib 400 Tablet)
Product Price: Rs 750 / StripeGet Best Price
Product Brochure
Product Details:
| Strength | 400 mg |
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Brand | Imatib |
| Packaging Type | Box |
| Manufactured by | Cipla |
| Medicine brand | Imatib 400 |
| Medicine form | Tablet |
| Medicine name | imatinib tablets ip 400 mg |
| Medicine strength | 400 mg |
| Packaging size | 10 tablets |
| Salt composition | Imatinib |
Yes! I am InterestedRequest A Callback
Cabolong Cabozantinib 40mg Tablet
Product Price: Rs 7,500 / BottleGet Best Price
Product Brochure
Product Details:
| Strength | 40 mg |
| Pack Size | 30 Tablets |
| Country of Origin | Made in India |
| Manufacturer | MSN Laboratories Pvt Ltd |
| Brand Name | Cabolong |
| Usage | Liver Cancer |
Description:
Cabozantinib is an oral medication that functions as a tyrosine kinase inhibitor. It targets multiple pathways involved in cancer cell growth and angiogenesis, making it effective in treating various malignancies by disrupting tumor blood supply and inhibiting cancer cell proliferation.
Indications:
Cabozantinib is indicated for the treatment of:
- Renal Cell Carcinoma (RCC): For patients with advanced renal cell carcinoma who have received prior therapy.
- Hepatocellular Carcinoma (HCC): For patients with advanced liver cancer who have previously been treated with sorafenib.
- Medullary Thyroid Cancer: For patients with metastatic medullary thyroid carcinoma.
Dosage and Administration:
- Dosage: The recommended dose is typically 40 mg taken once daily. The dosage may be adjusted based on patient tolerance and response to treatment.
- Administration: Cabozantinib should be taken orally, with or without food. It’s important to take the tablet at the same time each day to maintain consistent blood levels.
Common Side Effects:
- Fatigue
- Diarrhea
- Nausea and vomiting
- Loss of appetite
- Hypertension
- Hand-foot syndrome (palmar-plantar erythrodysesthesia)
Precautions:
- Liver Function: Monitor liver function tests, as cabozantinib can affect liver enzymes.
- Cardiovascular Monitoring: Regular blood pressure checks are advised due to the risk of hypertension.
- Drug Interactions: Inform your healthcare provider about all medications and supplements being taken, as cabozantinib can interact with various drugs.
Conclusion:
Cabozantinib (Cabolong 40 mg) is a targeted therapy used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. It is essential for patients to follow their healthcare provider's recommendations regarding dosage and administration and to report any side effects or concerns during treatment. Regular monitoring and follow-up appointments are crucial for optimizing treatment outcomes.
Yes! I am InterestedRequest A Callback
Everolimus Evertor 5mg Tablet
Product Price: Rs 1,700 / StripeGet Best Price
Product Brochure
Product Details:
| Strength | 5 mg |
| Form | Tablet |
| Drug Name | Everolimus 5 mg |
| Generic Name | Evertor 5 |
| Manufactured by | Biocon Biopharmaceutical company |
| Pack Size | 10 Tablets in 1 Strip |
| Treatment | Breast cancer Prevention of organ rejection in transplant patients, Lung cancer, Pancreatic cancer |
Everolimus (brand name Evertor) is an oral medication that belongs to a class of drugs known as mTOR inhibitors. It is primarily used in the treatment of various cancers, certain rare tumors, and for preventing organ rejection in transplant patients.
IndicationsEverolimus Evertor is indicated for:
- Cancer Treatment: Used in advanced renal cell carcinoma, neuroendocrine tumors, and hormone receptor-positive breast cancer.
- Organ Transplantation: Used to prevent rejection in patients receiving kidney transplants.
- Tuberous Sclerosis Complex: Treats non-cancerous tumors associated with this genetic disorder.
Everolimus works by inhibiting the mammalian target of rapamycin (mTOR), a key protein that regulates cell growth, proliferation, and survival. By blocking mTOR, Everolimus slows down the growth of cancer cells and suppresses the immune response to prevent organ rejection.
Dosage and Administration- Dosage: The usual starting dose for adults is 5 mg taken once daily, though this may vary based on the condition being treated and individual patient factors.
- Administration: Tablets should be taken orally, with or without food, at the same time each day for consistency. Do not crush or chew the tablets.
Everolimus Evertor is contraindicated in:
- Hypersensitivity: Known allergies to Everolimus or any components of the formulation.
- Pregnancy: Should not be used during pregnancy due to potential harm to the fetus.
- Infection Risk: Everolimus can suppress the immune system, increasing the risk of infections.
- Lung Problems: Monitor for signs of interstitial lung disease or pneumonitis, which can be serious.
- Kidney Function: Regular monitoring of kidney function is recommended, as the drug can affect renal health.
Common side effects may include:
- Mouth ulcers
- Nausea
- Fatigue
- Diarrhea
- Rash
Serious adverse effects can include:
- Severe infections
- Lung problems (pneumonitis)
- Liver function abnormalities
- Kidney problems
Everolimus can interact with several medications, including those that affect liver enzymes (CYP3A4). Patients should inform their healthcare provider of all medications, including over-the-counter drugs and supplements.
Storage InstructionsStore Everolimus Evertor tablets at room temperature, away from moisture and light. Keep out of reach of children.
Patient Counseling Information- Advise patients to report any signs of infection, severe gastrointestinal symptoms, or breathing difficulties.
- Emphasize adherence to dosing schedules and the importance of regular follow-up appointments for monitoring.
- Discuss potential lifestyle modifications to manage side effects and improve overall health.
Everolimus Evertor 5 mg Tablet is an important therapeutic option for various cancers and organ transplant patients. Effective management of therapy and monitoring for side effects are essential to optimize treatment outcomes and ensure patient safety.
Yes! I am InterestedRequest A Callback
Clomifene Tablets ( Clofi-50mg Tablets)
Product Price: Rs 215 / StripeGet Best Price
Product Brochure
Product Details:
| Strength | 50 mg |
| Form | Tablet |
| Packaging Type | Strip |
| Manufactured By | HBC Lifesciences Pvt Ltd |
| Usage/Application | Female infertility |
| Country of Origin | Made in India |
| Brand Name | CLOFI-50MG |
Indications: Clomifene is primarily indicated for:
- Treatment of ovulatory dysfunction in women who are trying to conceive. It is commonly used in cases of polycystic ovary syndrome (PCOS) or other conditions causing anovulation.
Mechanism of Action: Clomifene works as a selective estrogen receptor modulator (SERM). It stimulates the hypothalamus to release gonadotropin-releasing hormone (GnRH), which in turn increases the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. This promotes ovarian follicle development and ovulation.
Dosage and Administration:
- Typical Dosage: The usual starting dose is 50 mg taken orally once daily for 5 days, beginning on the 5th day of the menstrual cycle. If ovulation does not occur, the dose may be increased in subsequent cycles (up to 150 mg).
- Administration: Take the tablets as directed by a healthcare provider. It's important to follow the prescribed schedule and not to exceed the recommended dose.
Side Effects:
- Common: Hot flashes, mood swings, nausea, bloating, and breast tenderness.
- Serious: Ovarian hyperstimulation syndrome (OHSS), visual disturbances, and multiple pregnancies (e.g., twins).
Contraindications:
- Hypersensitivity to clomifene or any component of the formulation.
- Liver disease, uncontrolled adrenal or pituitary dysfunction, and ovarian cysts not related to PCOS.
Warnings and Precautions:
- Ovarian Hyperstimulation: Monitor for symptoms of OHSS, which can include abdominal pain, bloating, and rapid weight gain.
- Visual Disturbances: Caution patients to report any changes in vision.
- Multiple Pregnancies: Discuss the increased risk of multiple pregnancies with patients.
Drug Interactions: Clomifene may interact with other medications that affect hormonal balance or ovulation. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F), away from moisture and light.
Patient Counseling Information:
- Advise patients to take the medication exactly as prescribed and to track their menstrual cycles.
- Discuss potential side effects and the importance of reporting any concerning symptoms.
- Encourage patients to maintain regular follow-up appointments for monitoring ovulation and overall health.
Clomifene Tablets (Clofi 50 mg) are a key treatment for women with ovulatory dysfunction seeking to conceive. Patients should be well-informed about the medication, its effects, and the importance of medical supervision during treatment. Always consult a healthcare provider for personalized medical advice.
Yes! I am InterestedRequest A Callback
Invista Dasatinib 70 mg Tablets
Product Price: Rs 2,000 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 70 mg |
| Pack Size | 1*10 Tablet |
| Composition | Dasatinib 70 mg |
| Brand | Invista 70 mg |
| Manufactured By | Dr Reddy'S Laboratories Ltd |
| Treatment | Cancer/Oncology |
Invista Dasatinib 70 mg Tablets
Overview:
Invista (Dasatinib) is an oral tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL). It works by inhibiting the BCR-ABL1 tyrosine kinase, a protein that promotes cancer cell growth. By blocking this and other kinases, Invista slows the progression of leukemia and induces cancer cell death.
Indications:
Invista 70 mg is used for:
- Chronic Myelogenous Leukemia (CML): For patients with Ph+ CML in chronic, accelerated, or blast phase.
- Acute Lymphoblastic Leukemia (ALL): For Ph+ ALL, especially in patients resistant to other treatments.
- Other cancers: Sometimes used for additional hematological cancers under specialized protocols.
Mechanism of Action:
Dasatinib targets and blocks the BCR-ABL1 tyrosine kinase, a critical enzyme that causes uncontrolled leukemia cell growth. By inhibiting this enzyme, Dasatinib also affects other kinases, stopping cancer cell division and promoting cell death.
Dosage and Administration:
- Ph+ CML: The typical dose is 100 mg once daily for the chronic phase, and 140 mg once daily for accelerated or blast phase.
- Ph+ ALL: The recommended dose is 70 mg twice daily.
- Administration: Take on an empty stomach (at least 1 hour before or 2 hours after meals). Swallow whole; do not crush or chew.
- Missed dose: If a dose is missed, take it as soon as possible unless close to the next dose. Do not double the dose.
Side Effects:
Common side effects include:
- Fatigue
- Nausea
- Headache
- Rash
- Muscle pain
Serious side effects may include:
- Pulmonary arterial hypertension (PAH): A rare but serious lung condition.
- Bleeding: Increased risk of bleeding or bruising.
- Liver toxicity: Elevated liver enzymes.
- Fluid retention: Swelling in legs, ankles, or eyes.
- Cardiac issues: QT prolongation, arrhythmias.
Precautions:
- Pregnancy and breastfeeding: Should not be used during pregnancy or breastfeeding due to risks to the baby.
- Liver function: Regular liver enzyme tests are required.
- Heart conditions: Caution with QT prolongation. Patients with heart issues should be monitored.
- Drug interactions: Can interact with CYP3A4 inhibitors. Inform your doctor of all medications.
Monitoring:
- Blood counts: Regular CBC to check for bone marrow suppression.
- Liver function: Monitor liver enzyme levels.
- Heart function: Monitor for QT prolongation and other cardiac issues.
Storage:
Store Invista at room temperature (15°C to 30°C or 59°F to 86°F), in a dry place, away from heat and moisture. Keep out of reach of children.
Patient Counseling:
- Adherence: Take the medication as prescribed. Do not skip doses.
- Side effects: Report any unusual bleeding, difficulty breathing, or swelling.
- Hydration: Drink plenty of fluids to help manage side effects.
Conclusion:
Invista (Dasatinib) 70 mg Tablets is a potent treatment for Ph+ CML and Ph+ ALL, blocking critical cancer-related enzymes. Adherence to dosing, regular monitoring, and immediate reporting of side effects are essential for maximizing treatment benefits.
Yes! I am InterestedRequest A Callback
Spnib Dasatinib 100mg Tablet
Product Price: Rs 2,500 / BottleGet Best Price
Product Brochure
Product Details:
| Strength | 100 mg |
| Pack Size | 1*30 Tablet |
| Composition | Dasatinib 100 mg |
| Brand | Spnib 100 mg |
| Manufactured By | Zydus Cadila |
| Treatment | Philadelphia Chromosome-positive Chronic Myeloid Leukemia And Philadelphia Chromosome-positive Acute |
Spnib (Dasatinib) 100mg Tablet
Overview:
Spnib (Dasatinib) is an oral medication used in the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). It is a tyrosine kinase inhibitor (TKI) that blocks certain enzymes (such as BCR-ABL1 tyrosine kinase) involved in cancer cell growth, thereby slowing or halting the progression of leukemia.
Indications:
Spnib 100mg is indicated for:
- Chronic Myelogenous Leukemia (CML): In patients with Ph+ CML, particularly in the chronic, accelerated, or blast phases.
- Acute Lymphoblastic Leukemia (ALL): Specifically for Ph+ ALL in adult and pediatric patients who have not responded to other treatments.
- Other uses: Occasionally used in other hematological cancers under specialized care.
Mechanism of Action:
Dasatinib inhibits BCR-ABL1 tyrosine kinase, a key protein that drives cancer cell proliferation in Ph+ CML and ALL. By blocking this enzyme and related kinases, Spnib prevents the growth of cancer cells and promotes their death, helping to control the leukemia.
Dosage and Administration:
- Recommended dose: For CML, 100 mg once daily for chronic phase or 140 mg once daily for accelerated/blast phase. For Ph+ ALL, 70 mg twice daily.
- Administration: Take on an empty stomach, at least 1 hour before or 2 hours after meals. Swallow whole; do not crush or chew tablets.
- Missed dose: If a dose is missed, take it as soon as possible unless it's near the next dose. Do not double the dose.
Side Effects:
Common side effects include:
- Headache
- Fatigue
- Nausea
- Rash
- Muscle pain
Serious side effects may include:
- Pulmonary arterial hypertension (PAH), bleeding, liver problems (elevated liver enzymes), fluid retention, and heart issues (QT prolongation, arrhythmias).
Precautions:
- Pregnancy and breastfeeding: Not recommended during pregnancy or breastfeeding. Dasatinib can harm an unborn baby.
- Liver function: Monitor liver enzymes regularly to detect liver toxicity.
- Heart issues: Caution in patients with heart disease as Dasatinib can cause QT interval prolongation.
- Drug interactions: Dasatinib can interact with drugs that affect CYP3A4 enzymes. Inform your healthcare provider about all medications being taken.
Monitoring:
- Blood counts: Regular CBC to monitor bone marrow suppression (low blood counts).
- Liver function: Regular tests for liver enzymes to detect potential liver damage.
- Heart function: Monitor for signs of QT prolongation or heart problems.
Storage:
Store Spnib at room temperature (15°C to 30°C or 59°F to 86°F) in a dry place, away from heat and moisture. Keep out of reach of children.
Patient Counseling:
- Adherence: Take the medication exactly as prescribed. Do not skip doses.
- Side effects: Report any signs of bleeding, breathing difficulty, or swelling.
- Hydration: Drink plenty of fluids to help manage side effects.
Conclusion:
Spnib (Dasatinib) 100mg tablet is an effective treatment for Ph+ CML and Ph+ ALL, helping to slow cancer cell growth. Regular monitoring and adherence to the prescribed regimen are crucial for maximizing treatment benefits and minimizing side effects.
Yes! I am InterestedRequest A Callback
Cyclophosphamide 50mg Tablet (Adcyclo 50)
Product Price: Rs 150 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 50 mg |
| Packaging Size | 10 Tablets in 1 Strip |
| Composition | Cyclophosphamide 50 mg |
| Brand | Adcyclo 50 mg |
| Manufactured By | Adley Formulations |
| Treatment | Cancer And Nephrotic Syndrome (Kidney Disease) |
| Medicine brand | Adcyclo™ |
| Medicine form | Tablet |
| Medicine name | Cyclophosphamide tablets ip |
| Medicine strength | 50 mg |
| Packaging size | 5x10 tablets |
Yes! I am InterestedRequest A Callback
Abiraterone Acetate Tablets (Abione 250mg Tablets)
Product Price: Rs 3,500 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 250 mg |
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Box Contain | 120 Tab |
| Composition | Abiraterone Acetate |
Abiraterone Acetate Tablets (Abione 250mg Tablets)
Overview:
Abiraterone Acetate (Abione 250mg Tablets) is a medication used primarily for the treatment of prostate cancer, particularly in patients with metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting cytochrome P450 17A1 (CYP17A1), an enzyme involved in the production of androgens (male hormones like testosterone) in the body. By lowering androgen levels, Abiraterone reduces the growth of prostate cancer cells that rely on these hormones for proliferation.
Indications:
Abione 250mg Tablets are indicated for:
- Metastatic Castration-Resistant Prostate Cancer (mCRPC): Used in combination with prednisone to treat mCRPC, particularly in patients who have failed androgen deprivation therapy.
- Castration-Sensitive Prostate Cancer: May also be used in combination with other therapies for patients whose cancer is sensitive to castration.
Mechanism of Action:
Abiraterone acetate is a CYP17A1 inhibitor. CYP17A1 is responsible for producing androgens in the adrenal glands and prostate. By inhibiting this enzyme, Abiraterone reduces testosterone and other androgen production. This action deprives prostate cancer cells of the hormones they need to grow, leading to a reduction in tumor size and slowing disease progression.
Dosage and Administration:
- Recommended Dose: The typical dose is 1000 mg (four 250 mg tablets) once daily, taken with or without food.
- Administration: The tablets should be swallowed whole with water.
- Missed Dose: If a dose is missed, it should be taken as soon as possible, unless it is near the time for the next dose. Do not take two doses at once.
Side Effects:
Common side effects include:
- Fatigue, joint swelling, hot flashes, and diarrhea.
Serious side effects may include: - Hypertension (high blood pressure), hypokalemia (low potassium levels), and liver toxicity.
- Adrenal insufficiency: A potential issue due to reduced cortisol levels from inhibiting CYP17A1.
Precautions:
- Liver Function: Regular monitoring of liver enzymes is essential as Abiraterone may cause liver toxicity.
- Adrenal Insufficiency: Monitor for signs of adrenal insufficiency, and consider hydrocortisone supplementation.
- Pregnancy: Contraindicated in pregnant women as it may harm the fetus.
Storage:
Store Abione 250mg Tablets at room temperature (20°C to 25°C), away from moisture and light. Keep out of reach of children.
Conclusion:
Abione 250mg Tablets (Abiraterone acetate) is an effective treatment for advanced prostate cancer. By inhibiting androgen production, it slows the growth of cancer cells, improving outcomes in patients with metastatic castration-resistant prostate cancer. Regular monitoring is important to ensure safe and effective use of the medication.
Yes! I am InterestedRequest A Callback
Geftinat Tablet (Gefitinib 250 mg)
Product Price: Rs 3,000 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 250 mg |
| Pack Size | 30 Tablets in 1 Strip |
| Composition | Gefitinib 250 mg |
| Brand Name | Geftinat 250 mg |
| Manufacturer | Natco Pharma Ltd |
| Treatment | Non-small Cell Lung Cancer |
Geftinat Tablet (Gefitinib 250 mg)
Overview:Geftinat 250 mg Tablets contain Gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) used in the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. Gefitinib targets and blocks the EGFR receptor, which is involved in the growth and spread of cancer cells. By inhibiting EGFR, Gefitinib helps slow down the proliferation of cancer cells, reducing tumor size and improving patient survival rates. It is typically used in patients with advanced or metastatic NSCLC who have specific EGFR mutations.
Indications:Geftinat 250 mg Tablets are indicated for:
- Non-Small Cell Lung Cancer (NSCLC): For the treatment of locally advanced or metastatic NSCLC in adults whose tumors have specific EGFR mutations (exon 19 deletions or exon 21 L858R substitution) as detected by an approved diagnostic test.
- First-Line Treatment: For patients with EGFR mutation-positive NSCLC who have not received prior chemotherapy.
Gefitinib works by inhibiting the EGFR tyrosine kinase enzyme, a receptor that, when activated, triggers the growth and division of cancer cells. In NSCLC, mutations in the EGFR gene lead to uncontrolled cell growth. Gefitinib binds to the EGFR, preventing the receptor from activating the intracellular signaling pathways that drive cancer cell proliferation. This results in the inhibition of tumor growth and spread.
Dosage and Administration:- Recommended Dose: The usual dose of Geftinat 250 mg is one tablet once daily.
- Administration: The tablet can be taken with or without food. It should be swallowed whole with a glass of water. It is important to take the medication at the same time each day to maintain steady blood levels.
- Common Side Effects: Diarrhea, acneiform rash, nausea, loss of appetite, and fatigue.
- Serious Side Effects: Interstitial lung disease (ILD), hepatotoxicity, eye problems (e.g., dry eye, irritation), and gastrointestinal perforation. Liver function and lung symptoms should be monitored during treatment.
- Lung Disease: Use caution in patients with a history of lung disease, as Gefitinib may cause or worsen interstitial lung disease (ILD).
- Liver Disease: Patients with liver problems should be monitored closely, as Gefitinib can cause liver toxicity (elevated liver enzymes).
- Pregnancy: Gefitinib is Category D (may harm the fetus). It should be avoided during pregnancy unless the potential benefit justifies the risk.
- Drug Interactions: Gefitinib may interact with drugs that affect the CYP3A4 enzyme, which is involved in its metabolism. Consult your healthcare provider about other medications.
Store Geftinat 250 mg Tablets at room temperature (15°C to 30°C), away from light and moisture. Keep out of reach of children.
Conclusion:Geftinat 250 mg Tablets are a targeted therapy for patients with EGFR mutation-positive non-small cell lung cancer. When used appropriately, Gefitinib helps inhibit tumor growth and improve outcomes in advanced lung cancer. Regular monitoring for side effects, particularly lung and liver function, is essential for safe and effective treatment.
Yes! I am InterestedRequest A Callback
Busulfan Bucelon 2 mg Tablets
Product Price: Rs 180 / BoxGet Best Price
Product Brochure
Product Details:
| Packaging Size | 25 Tablets |
| Dose/Strength | 2 mg |
| Pack Size | 25 Tablets in 1 Pack |
| Composition | Busulfan 2 mg |
| Brand Name | Bucelon 2 mg |
| Manufactured By | Celon Laboratories Ltd |
| Treatment | Blood cancer |
| Manufactured by | Celon labs |
| Marketed by | Apnoa |
| Medicine brand | Bucelon 2 |
| Medicine form | Tablet |
| Medicine name | Busulphan tablets ip 2mg |
| Medicine strength | 2mg |
| Packaging size | 25 tablets |
Yes! I am InterestedRequest A Callback
Mercaptopurine (6-MP 50 mg Tablet)
Product Price: Rs 58 / BoxGet Best Price
Minimum Order Quantity: 10 Box
Product Brochure
Product Details:
| Strength | 50 mg |
| Pack Size | 10 Tablets in 1 Strip |
| Composition | Mercaptopurine 50 mg |
| Brand Name | 6-MP 50 mg Tablet |
| Manufactured By | Zydus Cadila |
| Treatment | Blood cancer (Acute lymphoblastic leukaemia) |
Mercaptopurine (6-MP 50mg Tablet)
Overview:
Mercaptopurine (6-MP) is an oral chemotherapy medication used to treat various cancers, including acute lymphoblastic leukemia (ALL) and chronic myelogenous leukemia (CML). It is also used as an immunosuppressive agent in the treatment of inflammatory bowel diseases (IBD) like Crohn’s disease and ulcerative colitis. Mercaptopurine is a purine analog, which works by inhibiting the synthesis of DNA and RNA in rapidly dividing cells, leading to cell death.
Indications:
Mercaptopurine 50mg tablet is primarily indicated for:
- Acute Lymphoblastic Leukemia (ALL): As part of combination chemotherapy regimens for treating ALL in children and adults.
- Chronic Myelogenous Leukemia (CML): Often used in the treatment of CML, usually after other therapies have failed.
- Inflammatory Bowel Disease (IBD): Used as an immunosuppressive agent to manage chronic Crohn’s disease or ulcerative colitis.
Mechanism of Action:
Mercaptopurine is a purine analog, which is metabolized in the body to thioguanine nucleotides. These active metabolites interfere with the synthesis of nucleic acids (DNA and RNA), inhibiting the replication of both cancer cells and rapidly dividing immune cells. This prevents the growth of tumors and modulates immune responses, which helps in the treatment of both cancer and autoimmune diseases.
Dosage and Administration:
- Recommended Dose: The dose of Mercaptopurine varies depending on the condition being treated and the patient's age, weight, and medical condition.
- Administration: Mercaptopurine 50mg tablets should be taken once daily, preferably at the same time each day. The tablets should be swallowed whole with water.
- Missed Dose: If a dose is missed, it should be taken as soon as possible, unless it is almost time for the next dose. Do not double doses.
Side Effects:
Common side effects include:
- Nausea, vomiting, loss of appetite, and fatigue.
Serious side effects may include: - Bone marrow suppression: Low blood counts, which increase the risk of infection, bleeding, and anemia.
- Hepatotoxicity: Liver damage, including elevated liver enzymes and jaundice.
- Pancreatitis: Inflammation of the pancreas, which may cause abdominal pain and digestive problems.
Precautions:
- Liver Disease: Mercaptopurine requires careful monitoring of liver function, as it can cause liver toxicity.
- Bone Marrow Suppression: Regular blood tests are necessary to monitor blood cell counts.
- Pregnancy: Should be avoided during pregnancy due to potential harm to the fetus.
Storage:
Store Mercaptopurine 50mg tablets at room temperature (20°C to 25°C), in a dry place, away from moisture, light, and out of the reach of children.
Conclusion:
Mercaptopurine 50mg tablets are effective for treating acute lymphoblastic leukemia, chronic myelogenous leukemia, and inflammatory bowel diseases. It requires careful monitoring due to potential side effects like bone marrow suppression, liver toxicity, and pancreatitis. Patients should follow the prescribed regimen and undergo regular lab tests to ensure safety.
Yes! I am InterestedRequest A Callback
Abstet Abiraterone Acetate 250 mg Tablet
Product Price: Rs 35,000 / BottleGet Best Price
Product Brochure
Product Details:
| Strength | 250 mg |
| Packaging Size | 120 Tablets in 1 Bottle |
| Composition | Abiraterone Acetate 250 mg |
| Brand Name | Abstet 250 mg Tablet |
| Manufacturer | Biocon |
| Treatment | Prostate Cancer |
| Manufactured by | Biocon |
| Medicine form | Tablet |
| Medicine name | Abiraterone acetate tablets |
| Medicine strength | 250mg |
| Packaging size | 120 |
| Packaging type | Box |
Yes! I am InterestedRequest A Callback
Abiraterone Acetate Tablets (Abirakast 250 mg Tablet)
Product Price: Rs 13,500 / BottleGet Best Price
Product Brochure
Product Details:
| Strength | 250 mg |
| Packaging Size | 120 Tablets in 1 Bottle |
| Composition | Abiraterone Acetate 250 mg |
| Brand | Abirakast 250 mg Tablet |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Treatment | Prostate cancer |
| Medicine brand | Abirakast |
| Medicine form | Tablet |
| Medicine name | Abiraterone acetate tablets ip |
| Medicine strength | 250 mg |
Yes! I am InterestedRequest A Callback
Abiraterone Acetate Tablets (Ahabir 250mg Tablet)
Product Price: Rs 22,500 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 250 mg |
| Packaging Size | 120 Tablets in 1 Bottle |
| Composition | Abiraterone Acetate 250 mg |
| Brand | Ahabir 250 mg Tablet |
| Manufacturer | Hetero Drugs Ltd |
| Treatment | Prostate Cancer |
| Medicine name | abiraterone acetate tablets ip 250 mg ahabir เคเคนเคพเคตเฅเคฐ |
| Medicine strength | 250 mg |
| Packaging size | 120 |
Yes! I am InterestedRequest A Callback
Abiraterone Acetate Tablet (arbitus Tablet 500 mg)
Product Price: Rs 30,000 / BottleGet Best Price
Product Brochure
Product Details:
| Strength | 500 mg |
| Packaging Size | 60 Tablets In 1 Bottle |
| Composition | Abiraterone Acetate 500 mg |
| Brand Name | Arbitus Tablet |
| Manufacturer | Dr Reddy's Laboratories Ltd |
| Treatment | Prostate cancer |
| Medicine brand | Arbitus™ 500 |
| Medicine form | Tablet |
| Medicine name | Abiraterone acetate tablets i.p. |
| Medicine strength | 500mg |
| Packaging size | 60 tablets |
| Packaging type | Bottle |
Yes! I am InterestedRequest A Callback
Erleada 60 mg Tablets (Apalutamid)
Product Price: Rs 13,500 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 60 mg |
| Composition | Apalutamide Tablet |
| Brand Name | Erleada 60 mg |
| Manufacturer | Apalutamide |
| Treatment | Non-metastatic Castration-resistant Prostate Cancer |
| Medicine name | Apalutamid filmtabletten --Erleada |
| Medicine strength | 60 mg |
| Packaging size | 112 |
| Packaging type | Filmtabletten |
Yes! I am InterestedRequest A Callback
20mg Cabolong Cabozantinib Tablet
Product Price: Rs 5,700 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 20 mg |
| Pack Size | 30 Tablets |
| Form | Tablet |
| Treatment | Treat thyroid cancer |
| Brand | MSN |
| Pack Type | Box |
| Shelf Life | 24 Months |
Cabolong 20 mg Tablet should be taken on an empty stomach, but try to have it at the same time every day to get the most benefits. Your croaker will decide what cure is necessary and how frequently you need to take it. This will depend on what you're being treated for and may change from time to time. Take it exactly as advised by the croaker . Taking it in the wrong way or taking too much can beget veritably serious side goods. It may take several weeks or months for you to see or feel the benefits but don't stop taking it unless your croaker tells you to.
Fatigue, nausea, loss of appetite, taste change, and diarrhea are some of the common side goods of Cabolong 20 mg Tablet. It might beget high blood pressure, so the croaker may ask you for a regular check up of blood pressure. You must inform your croaker if you notice a severe skin response, similar as skin rash or any pain, swelling, and greenishness of your hands and bases.
Yes! I am InterestedRequest A Callback
View More